Sudden Cardiac Death News and Research

RSS

The term sudden cardiac death refers to natural death from cardiac causes, heralded by abrupt loss of consciousness within one hour of the onset of acute symptoms.

Researchers demonstrate advantages of implanted defibrillator in preventing non-ischaemic heart failure

Sudden cardiac arrest is a possible cause of death in patients with non-ischaemic cardiac muscle weakness, i.e. a type of heart failure caused by genetics or for which no cause is known. Now, researchers at the University Department of Internal Medicine II at the MedUni Vienna (Clinical Department of Cardiology), as part of an international cooperation, have successfully demonstrated the advantages of an implanted defibrillator (ICD) as a means of prevention in patients with moderately restricted cardiac function, and that patients with the condition must be treated as carefully as patients with ischaemic heart failure which has developed following a heart attack, for example.

16 Feb 2015

ISP shows promise in stopping fatal arrhythmias after heart attack

Case Western Reserve's chemical compound aimed at restoring spinal cord function may have an additional purpose: stopping potentially fatal arrhythmias after heart attack.

3 Feb 2015

Unique project launched to identify effects of exercise on young people's hearts

A unique research project to identify the effects of exercise on young hearts has been announced today.

30 Jan 2015

Innovative software predicts sudden cardiac death in patients at risk of arrhythmia

At Galway Hospital, in Ireland, a device is currently used to "predict" cardiac events in people at risk of sudden cardiac death.

24 Dec 2014

CVRx receives HDE approval for Barostim neo legacy device

CVRx, Inc., a privately held medical device company, announced today that it has received Humanitarian Device Exemption (HDE) approval from the U.S. Food and Drug Administration for its Barostim neo legacy device.

16 Dec 2014

CVRx gets CE Mark approval to expand labeling of Barostim neo System as MR Conditional

CVRx, Inc., a privately held medical device company, announced today that CE Marking has been granted to expand labeling of the Barostim neo System as MR Conditional, or safe for use in Magnetic Resonance Imaging (MRI) systems under specified conditions.

11 Dec 2014

Reducing the risk of sudden cardiac arrest during sports

Time and again, the topic of sudden cardiac death grabs the public's attention when football stars or other top athletes collapse from cardiac arrest in front of the live cameras. This important issue has long been a concern of heart specialists, for cardiac arrest often hits young, apparently healthy and athletic people out of the blue.

11 Dec 2014

Advances in fight against TB, sudden cardiac death

Research projects into two of the biggest killers in worldwide health, tuberculosis and sudden cardiac death, will be the subjects of the University of Leicester Graduate School Doctoral Inaugural Lectures, delivered by two of the winners of this year's PhD prizes in the College of Medicine, Biological Sciences and Engineering.

10 Dec 2014

Researchers assess efficiency and safety of breast milk stimulant

Most women can make all the milk their baby needs, but some mothers turn to medications to help increase their supply. While some specialists encourage the off-label use of domperidone to stimulate breast milk production, some studies have suggested it may be related to negative side effects, including irregular heartbeat and sudden cardiac death.

6 Dec 2014

Johns Hopkins researchers capture images of protein complex that keeps hearts beating

For years, a multidisciplinary team of Johns Hopkins researchers has tracked an elusive creature, a complex of proteins thought to be at fault in some cases of sudden cardiac death. As they report Nov. 5 in the online edition of Nature Communications, they have finally captured images of the complex.

6 Nov 2014

Initiative may allow 'instantaneous diagnosis of potentially fatal rhythm disorders' in endurance athletes

The condition of an athlete's heart has for the first time been accurately monitored throughout the duration of a marathon race. The real-time monitoring was achieved by continuous electrocardiogram (ECG) surveillance and data transfer over the public mobile phone network to a telemedicine centre along the marathon route.

31 Oct 2014

Study: Certain prostate cancer medications linked to cardiac death risk

A new study has found that certain prostate cancer medications are linked with an increased risk of dying from heart-related causes in men with congestive heart failure or prior heart attacks. Published in BJU International, the findings will help doctors and patients weigh the benefits and risks of the drugs.

30 Oct 2014

Women delay seeking medical care for heart symptoms, put health at risk

When heart symptoms strike, men and women go through similar stages of pain but women are more likely to delay seeking care and can put their health at risk, according to a study presented at the Canadian Cardiovascular Congress.

29 Oct 2014

Study: Tbx5 protein contributes to formation of epicardium, pericardium, coronary vessels

Congenital heart defects are the most common birth defect, affecting 8 out of every 1,000 newborns according to the National Heart, Lung and Blood Institute. In the U.S., more than 35,000 babies are born annually with some sort of heart defect.

16 Oct 2014

U-M implants CoreValve Evolut R System in patients with severe aortic stenosis

The University of Michigan Frankel Cardiovascular Center is one of the first hospitals in the country to implant Medtronic's new investigational device during transcatheter aortic valve replacement (TAVR).

From Medtronic 9 Oct 2014

CVRx Barostim neo System receives CE Mark approval from NSAI for treatment of heart failure

CVRx, Inc., a private medical device company, announced today it received CE Mark approval from the National Standards Authority of Ireland of the Barostim neo System for the treatment of heart failure.

29 Sep 2014

3D-printed heart model created by Materialise

Materialise (Nasdaq:MTLS), a pioneer in 3D Printing for medical applications, recently created a 3D-printed heart model for doctors at Cincinnati Children’s Hospital to support Bradley White’s case, a 16-year-old boy who was born with a tumor. With the aid of Materialise’s HeartPrint® 3D-printed model, his doctors were able to determine the best treatment for Bradley’s erratic heartbeat.

From Materialise 17 Sep 2014

Sudden Cardiac Death News and Research

Further Reading

Researchers demonstrate advantages of implanted defibrillator in preventing non-ischaemic heart failure

ISP shows promise in stopping fatal arrhythmias after heart attack

Unique project launched to identify effects of exercise on young people's hearts

Innovative software predicts sudden cardiac death in patients at risk of arrhythmia

CVRx receives HDE approval for Barostim neo legacy device

CVRx gets CE Mark approval to expand labeling of Barostim neo System as MR Conditional

Reducing the risk of sudden cardiac arrest during sports

Advances in fight against TB, sudden cardiac death

Researchers assess efficiency and safety of breast milk stimulant

Johns Hopkins researchers capture images of protein complex that keeps hearts beating

Initiative may allow 'instantaneous diagnosis of potentially fatal rhythm disorders' in endurance athletes

Study: Certain prostate cancer medications linked to cardiac death risk

Women delay seeking medical care for heart symptoms, put health at risk

Study: Tbx5 protein contributes to formation of epicardium, pericardium, coronary vessels

U-M implants CoreValve Evolut R System in patients with severe aortic stenosis

CVRx Barostim neo System receives CE Mark approval from NSAI for treatment of heart failure

3D-printed heart model created by Materialise

Measuring levels of sex hormones in patients' blood may identify risk of sudden cardiac arrest

Novel document on ventricular arrhythmias published in EP Europace

ESC Guidelines on diagnosis and treatment of aortic diseases published in European Heart Journal

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News